DLA Piper advised Benchmark Holdings plc on the deal. Benchmark Holdings plc, a market leading aquaculture genetics, specialist nutrition and health business, announced the sale of...
Novo Holdings’ Acquisition of Genetics Business from Benchmark Holdings
Grey Wolf Therapeutics’ $49 Million Series B Funding Round
Goodwin Procter advised Grey Wolf Therapeutics on the deal, while DLA Piper advised Pfizer Ventures and Earlybird Venture Capital. Grey Wolf Therapeutics announced its $49 million Series B...